Jen Nwankwo

Jen Nwankwo, Ph.D., is the Founder and CEO of 1910 Genetics, a Boston-based, Series A stage biotechnology company that is advancing small and large molecule drug discovery with a multimodal AI platform powered by laboratory automation.

Prior to 1910 Genetics, Jen was a Management Consultant at Bain and Company and Director of Business Development at Transparency Life Sciences. She received her Ph.D. in Pharmacology and Experimental Therapeutics from Tufts University School of Medicine, and conducted part of her doctoral research at the Boston Children’s Hospital of Harvard Medical School.

Jen was recently named by Endpoints News as one of the “Top 20 Women in Biopharma R&D” and one of “52 Women-Led Startups Driving The Future of HealthTech and FemTech” by Forbes Magazine.